These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 8602994)

  • 1. Bencyclane as an anti-sickling agent.
    Koçak R; Başlamişli F; Güvenç B; Tamer L; Aikimbaev KS; Isbir T
    Br J Haematol; 1996 Feb; 92(2):329-31. PubMed ID: 8602994
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapy with oral clotrimazole induces inhibition of the Gardos channel and reduction of erythrocyte dehydration in patients with sickle cell disease.
    Brugnara C; Gee B; Armsby CC; Kurth S; Sakamoto M; Rifai N; Alper SL; Platt OS
    J Clin Invest; 1996 Mar; 97(5):1227-34. PubMed ID: 8636434
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sodium-potassium pump, ion fluxes, and cellular dehydration in sickle cell anemia.
    Izumo H; Lear S; Williams M; Rosa R; Epstein FH
    J Clin Invest; 1987 Jun; 79(6):1621-8. PubMed ID: 3034977
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Erythrocyte dehydration in pathophysiology and treatment of sickle cell disease.
    Brugnara C
    Curr Opin Hematol; 1995 Mar; 2(2):132-8. PubMed ID: 9371983
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of a 'sickling pulse' on calcium and potassium transport in sickle cell trait red cells.
    Bookchin RM; Lew VL
    J Physiol; 1981 Mar; 312():265-80. PubMed ID: 7264994
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An explanation for the efficacy of procaine in the treatment of sickle cell anaemia.
    Abu-Salah KM; Gambo AH
    Int J Biochem Cell Biol; 2005 Apr; 37(4):835-41. PubMed ID: 15694842
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The calmodulin-stimulated (Ca2+ + Mg2+)-ATPase in hemoglobin S erythrocyte membranes: effects of sickling and oxidative agents.
    Leclerc L; Girard F; Galacteros F; Poyart C
    Biochim Biophys Acta; 1987 Feb; 897(1):33-40. PubMed ID: 2948569
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Erythrocyte and plasma Ca2+, Mg2+ and cell membrane adenosine triphosphatase activity in patients with essential hypertension.
    Fu Y; Wang S; Lu Z; Li H; Li S
    Chin Med J (Engl); 1998 Feb; 111(2):147-9. PubMed ID: 10374376
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of calcium antagonists on heart sarcolemmal (Na+ + K(+)-ATPase.
    Dzurba A; Breier A; Slezák J; Stankovicová T; Vrbjar N; Ziegelhöffer A
    Bratisl Lek Listy; 1991; 92(3-4):155-8. PubMed ID: 1851463
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence for a direct reticulocyte origin of dense red cells in sickle cell anemia.
    Bookchin RM; Ortiz OE; Lew VL
    J Clin Invest; 1991 Jan; 87(1):113-24. PubMed ID: 1702096
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative evaluation of fifteen anti-sickling agents.
    Chang H; Ewert SM; Bookchin RM; Nagel RL
    Blood; 1983 Apr; 61(4):693-704. PubMed ID: 6338971
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Calmodulin-stimulated plasma membrane (Ca2+ + Mg2+)-ATPase: inhibition by calcium channel entry blockers.
    Raess BU; Gersten MH
    Biochem Pharmacol; 1987 Aug; 36(15):2455-9. PubMed ID: 3038124
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of cetiedil on monovalent cation permeability in the erythrocyte: an explanation for the efficacy of cetiedil in the treatment of sickle cell anemia.
    Berkowitz LR; Orringer EP
    Blood Cells; 1982; 8(2):283-8. PubMed ID: 7159752
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Additive in vitro effects of anti-sickling drugs.
    Stuart J; Mojiminiyi FB; Stone PC; Culliford SJ; Ellory JC
    Br J Haematol; 1994 Apr; 86(4):820-3. PubMed ID: 7918079
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improvements in haemolysis and indicators of erythrocyte survival do not correlate with acute vaso-occlusive crises in patients with sickle cell disease: a phase III randomized, placebo-controlled, double-blind study of the Gardos channel blocker senicapoc (ICA-17043).
    Ataga KI; Reid M; Ballas SK; Yasin Z; Bigelow C; James LS; Smith WR; Galacteros F; Kutlar A; Hull JH; Stocker JW;
    Br J Haematol; 2011 Apr; 153(1):92-104. PubMed ID: 21323872
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Understanding antisickling agents and the sickling process.
    Godwin M; Baysinger M
    Nurs Clin North Am; 1983 Mar; 18(1):207-14. PubMed ID: 6550864
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of 1-chloro-2,4-dinitrobenzene on K+ transport in normal and sickle human red blood cells.
    Muzyamba MC; Gibson JS
    J Physiol; 2003 Mar; 547(Pt 3):903-11. PubMed ID: 12576491
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hydroxyurea and sickle cell anemia. Clinical utility of a myelosuppressive "switching" agent. The Multicenter Study of Hydroxyurea in Sickle Cell Anemia.
    Charache S; Barton FB; Moore RD; Terrin ML; Steinberg MH; Dover GJ; Ballas SK; McMahon RP; Castro O; Orringer EP
    Medicine (Baltimore); 1996 Nov; 75(6):300-26. PubMed ID: 8982148
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Viscosity and filtrability measurements of sickle-cell suspensions in the development of anti-sickling drugs.
    Ohnishi ST
    Blood Cells; 1982; 8(1):79-87. PubMed ID: 7115980
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The ATPase activity of saponin-treated rat erythrocytes: regulation by monovalent cations, calcium, ouabain, and furosemide.
    Petrunyaka VV; Panyushkina EA; Severina EP; Orlov SN
    Biochim Biophys Acta; 1990 Dec; 1030(2):279-88. PubMed ID: 2175654
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.